Add this result to my export selection For women with heavy menstrual bleeding, how do antifibrinolytics compare with placebo? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 gastrointestinal effects, headache, uterine cancer, vaginal dryness, dysmenorrhea, thromboembolic events, or anemia. Most of the events... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy menstrual bleeding, how does tranexamic acid (TXA) compare with progestogens? Source: Cochrane Clinical Answers (Remove filter) 23 August 2018 assessed (gastrointestinal, vertigo, headache, bleeding, breast tenderness, dysmenorrhea, weight gain, allergic reaction, giddiness,... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with heavy bleeding or pain associated with intrauterine device (IUD) use, how do non‐steroidal anti‐inflammatory drugs (NSAIDs) compare with placebo, each other, or alternative analgesics? Source: Cochrane Clinical Answers (Remove filter) 06 February 2020 versus placebo Expand All OUTCOME 1.1 IUD removal by 26 weeks for dysmenorrhea or increased menstrual blood loss Narrative result One... Type: Systematic Reviews (Remove filter)
Add this result to my export selection For women with endometriosis, what are the effects of presurgical and postsurgical medical therapy? Source: Cochrane Clinical Answers (Remove filter) 21 January 2021 symptomatic endometriosis or stage III–IV endometriosis, pelvic pain, dysmenorrhea, or dyspareunia undergoing surgery. Trials were... Type: Systematic Reviews (Remove filter)
Add this result to my export selection In women undergoing surgery for uterine fibroids, how do preoperative gonadotropin‐releasing hormone analogues (GnRHa) compare with placebo or no treatment? Source: Cochrane Clinical Answers (Remove filter) 24 July 2018 they observed no apparent differences between groups for hypermenorrhea, dysmenorrhea, pelvic pain, dyspareunia and difficult defecation... Type: Systematic Reviews (Remove filter)
Add this result to my export selection Evidence review: Gender-affirming hormones for children and adolescents with gender dysphoria Source: National Institute for Health and Care Excellence - NICE (Remove filter) Source: NHS England (Add filter) Source: NHS Improvement (Add filter) Published by National Institute for Health and Care Excellence (NICE);NHS England;NHS Improvement, 11 March 2021 This document will help inform Dr Hilary Cass’ independent review into gender identity services for children and young people. It was commissioned by NHS England and Improvement who commissioned the... Read Summary Type: Evidence Summaries (Remove filter)